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Introduction
The Population Council (through the STEP UP consortium and the Evidence Project) and the High Impact
Practices (HIP) Collaboration, together with other partners, held a series of three consultative meetings
around the topic of standards of evidence in reproductive and maternal health. The first consultation was
held in New York (18-19 June 2013) and focused on the generation and synthesis of evidence to inform the
production of HIP briefs. The second consultation was held in Croydon, UK (18-19 September 2013) and
brought together researchers and funders of research to discuss and develop recommendations to improve
research design and methodologies to generate evidence on the implementation and impact of FP/RH
interventions; review mechanisms and structures for this evidence; and maximize quality and utility of
evidence generation.
The third and final meeting in the series was held in Bellagio, Italy from 9-11 February 2016. The meeting
brought together developing country decision-makers (see Annex B for participant list) to vet, from the
research “consumer” perspective, the recommendations that emerged from the second consultation and to
elicit further recommendations on how to better generate and package evidence to meet the needs of
decision-makers. Also in attendance were donors, multi-lateral organizations, and researchers from the
second consultation, so that they could better understand the decision-makers’ perspectives and to forge
connections between “producers” and “consumers” of evidence.

Objectives
Nineteen developing country decision-makers, representatives of donors and multi-lateral organizations, and
researchers participated in the two-and-a-half day meeting. The meeting was structured in a participatory
format, with a moderator initiating and facilitating discussion among participants. Most session moderators
were country decision-makers.
The goals of the Bellagio meeting were to:
§ Share with national decision-makers the recommendations for standards of evidence developed
during the two previous consultations, including types of studies, to determine their applicability in
developing country contexts;
§ Understand with greater insight how research evidence, along with other types of evidence, is
currently used by national decision-makers and the factors facilitating or inhibiting use of evidencebased best practice recommendations;
§ Reach agreement on how research can be designed and implemented to best help national decisionmakers achieve their goals;
§ Reach agreement on how research results can be synthesized, packaged, and communicated most
appropriately for informing the various types of decisions made by national and sub-national health
system stakeholders.
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Key Points of Discussion
On the first morning, to help frame the discussion, Dr. Ian Askew from the World Health Organization
(WHO) provided a brief overview of the second consultation at Croyden and the relevant recommendations
that emerged from that meeting (see Annex A for full agenda).
Following this synopsis, Dr. Patrick Aboagye from the Ghana Health Service led a country decision-maker
discussion on the topic of “policy and programs from the decision-maker perspective,” and the role for
research-based evidence, with the intent of eliciting the decision-makers’ real life experiences and challenges
around evidence use. An Evidence Project working paper titled “Family Planning Policy, Program, and
Practice Decision-making: The Role of Research Evidence and Other Factors 1” found that decision-makers
often have a broader definition of “evidence” than researchers, that evidence tends to be just one of many
factors in decision-making, and that evidence use is a non-linear process, with use occurring at various points
in the decision-making process. Discussion among participants reinforced all of these points, particularly that
evidence use is not always a uniform part of decision-making, but rather can occur at various stages and for
various purposes in the decision-making process. For example, some decisions have to be made very quickly
and there is not time for rigorous research designs to answer the question – decision-makers need to reach
out to the most convenient, readily available source for evidence. In other instances, evidence is sought to
justify continued investment in a decision that has already been made. These examples highlight the
complexity and challenges of evidence-based decision-making.
0F

Key issues were raised around the themes of what types of evidence consumers want, as well as the time it
takes to generate this evidence through research. Decision-makers made the point that they are often not
looking for evidence from randomized controlled trials or systematic reviews, but operational evidence that
can inform program investments and their implementation. A challenge for decision-makers as research
consumers is the time required to conduct primary research that may be necessary to generate the
information needed for them to use to improve programming.
Decision-makers also raised the issue that politicians often look to them for very quick, evidence-informed
answers to questions so that they can rapidly respond to issues arising in parliament or among their
constituents. This presents a challenge, as undertaking research is not an option in these situations, given time
constraints. Decision-makers need options to access rigorous evidence quickly to be able to respond to these
requests. The group discussed existing examples of rapid response mechanisms, although the definition of
“rapid” varies and it is not clear how sustainable these mechanisms are without donor funding.
Another issue raised in this session is communication between researchers and decision-makers on how
research agendas are identified, as well as on whether the results produced from research are relevant for
decision-makers. It is important to balance research agendas of external donors who fund the studies to
achieve their goals with those of country decision-makers who need the evidence to improve their programs.
Research prioritization should start with dialogue between donors, researchers and policy makers so that
those expected to use the evidence are aware of and understand the research being done - in the absence of
dialogue and understanding, decision-makers can become barriers to conducting and using research, rather
than champions. Dialogue would also help to align the research with country needs, thereby gaining buy-in
from key end users. The discussion also highlighted many common challenges of ensuring that the research
consumers have knowledge of and access to the results once the research is completed; for example, all

1

http://evidenceproject.popcouncil.org/wp-content/uploads/2015/09/Role-of-Evidence-Working-Paper.pdf
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participants emphasized the importance of open access to journal publications to remove cost barriers to
country end users.
Decision-makers emphasized that the government needs to be closely connected to research from the
beginning, so that scale up of the results is accepted as the responsibility of the government and not just a
recommendation given to them at a dissemination meeting, with no plan for implementation. Sometimes
decision-makers aren’t even aware of relevant research that was done in their country and only learn of it at a
conference or similar venue, which shows a potential disconnect between producers and consumers of
research.
Following this discussion, key issues related to standards of evidence were discussed, with presentations by
Karen Hardee of the Population Council and Director of the Evidence Project, Nhan Tran from the WHO,
and Özge Tunçalp from the WHO.
Dr. Hardee gave a presentation on “Standards and Types of Evidence for Clinical, Public Health, and
Multisectoral Interventions.” She discussed the importance of using different study designs depending on the
evidence needed, as they can answer different types of questions and add greater nuance to the evidence. For
example, as shown in Figure 1, qualitative evidence is useful for assessing service delivery processes,
acceptability, appropriateness, and service satisfaction, as it gets to people’s perceptions and adds important
context to the quantitative data.
FIGURE 1 | EXAMPLE OF A TYPOLOGY OF EVIDENCE FOR SOCIAL INTERVENTIONS
FOR CHILDREN

Dr. Hardee also stressed that researchers should be flexible in designing their studies in order to meet the
needs of the end user (while retaining its rigor and high quality) and that the results should be implementable
by national programs. Finally, she discussed what is known about how decision-makers use research evidence
in the decision-making process, including how it is supplemented with other types of evidence, such as
personal or professional experience and anecdotal evidence, and how research evidence is perceived through
an individual’s beliefs and values, as well as external constraints, before a decision is made.
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Dr. Tran then presented on using implementation research to inform scale up and improve program
efficiency. He discussed the need for research to be more dynamic and iterative, rather than producing linear
outputs, outcomes, and impact, since policy making and implementation is not always a rational, linear
process. Echoing Dr. Hardee, he noted that it is incorrect to assume that there is a single solution to complex
challenges, i.e. that one research design can answer multiple questions. Dr. Tran also made the point that
implementation of research findings often has to be done with limited information. A report entitled
“Enabling efficient policy implementation” 2 found that poor implementation is widespread, with common
reasons including poor planning, the complexity of consistent implementation, and push-back or lack of
interest from health professionals responsible for implementation. Finally, research needs to take the social
and political context and health systems into consideration, and take advantage of unexpected opportunities
that may present themselves.
1F

Dr. Tunçalp closed the session by presenting on “From Evidence to Guidelines: what’s in an acronym?” She
summarized the WHO guideline development process and the effort to make the guidelines more focused on
questions not just of effectiveness, but also acceptability and feasibility, which are issues important to
decision-makers. This was done through the development of the DECIDE (Developing and Evaluating
Communication Strategies to Support Informed Decisions and Practice Based on Evidence) framework
(which is complementary to the GRADE (Grading of Recommendations Assessment, Development and
Evaluation) framework). In the WHO guideline development process, questions of efficacy and safety are
answered with systematic reviews of controlled studies, while acceptability and feasibility are answered with
systematic reviews of qualitative research. To answer the question of how decision-makers, who are often not
themselves research experts, can be confident in the quality of evidence, particularly qualitative evidence, Dr.
Tuncalp reviewed the GRADE CERQual (Confidence in the Evidence from Reviews of Qualitative research)
process. Finally, the presentation closed with an overview of the ongoing process to help make global level
guidelines more useful and easier to adapt and implement at the country level.
Day one closed with a discussion of the role of politics and opinion in assessing standards of evidence,
facilitated by Dr. Josephine Kibaru from the National Council for Population and Development in Kenya.
The discussion covered a variety of challenges, including the need for consensus building and to engage a
variety of politicians at different levels, not just the federal level. Increased decentralization makes this
especially important: even if research results in a policy change at the federal level, implementation of the new
policy could be hindered if sub-national level politicians and decision-makers were not involved, particularly if
the change required is substantial. There can also be political challenges to bringing in evidence and
experiences from other countries, as there can be sensitivity around which countries are used for comparison.
Conversely, countries will often find global evidence insufficient and will want research on how a policy or
intervention would work locally before implementation.
A number of issues were cited related to the influence of political factors on evidence use in decision-making.
This included frequent turnover of politicians at the highest levels of decision-making, though it was noted
that engaging civil servants, who tend to stay in their positions for longer periods, can mitigate that. Political
hierarchy can also hinder the use of research evidence in policy making since, for example, it can be difficult
to ensure that research evidence is communicated effectively through the hierarchy to reach the highest levels
of decision-making. Professional associations and nongovernmental organizations were mentioned as
stakeholders that should be engaged to help overcome these challenges, as they can be very influential in the
policy process. Another method to overcome political challenges is the identification of effective champions
who can help to ensure that evidence and accurate information reaches politicians.

2
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Day two opened with a discussion among country decision-makers, facilitated by Susan Elden from DfID, of
their perspectives on country-level research agendas, research coordination, and challenges to evidence
generation or access to evidence at the country level. It was agreed that decision-makers generally do not have
the ability or time to determine the quality of research evidence on their own; discussion focused on if and
how in-country arbiters of good and poor research methodology could help decision-makers assess the
quality of evidence from national and international sources. Potential arbiters of research evidence included
universities, professional associations, or technical working groups that have credibility. In Bangladesh, for
example, professional associations are engaged in research review. Generally, it was agreed that there is not a
one-size-fits-all solution and that each country needs to determine for themselves what entities could play this
role. There was agreement, however, that decision-makers do need a mechanism to help them judge the
quality of research, since the quality will impact the results. Discussion concluded with a conversation about
whether more global guidance is needed to help country decision-makers assess the quality of evidence,
similar to guidance 3 that DfID has produced.
2F

Dr. Koku Awoonor-Williams from the Ghana Health Service facilitated a discussion among the researchers,
multi-lateral representatives, and donors to discuss their perspectives on these topics, including if and how
research needs to better align with country research agendas and how research can be better coordinated
among all partners. This discussion also addressed the importance of donors having more of a culture of
embedding research and learning into program implementation and a more diverse portfolio of research
mechanisms (seed grants, grand challenges, implementation research, clinical trials, and so forth) to enable
more country-level opportunities for different stakeholders to be involved in the research process.
Discussion for the remainder of the second day covered packaging and communication of evidence. Three
means of communicating evidence were reviewed and discussed (a single journal article, High Impact Practice
briefs, and WHO global guidance) to gain decision-maker perspectives on the usefulness of these documents
in their current form and what could be done to make them more understandable and accessible to encourage
use. The discussion also focused on what types of evidence the decision-makers preferred, what they would
like more of, and what they felt were the most effective methods of communicating evidence to decisionmakers. The importance of open access journals was reiterated, as the requirement to pay or have a
subscription to access an article can be a hindrance for decision-makers to access evidence.
Other important suggestions made by the decision-makers for how better to communicate evidence include:
§ Presentations on research evidence to targeted sub-groups
§ Use of concise summaries and plain language in communication of evidence
§ Sending research reports (or briefs with key information from the report) to ministries
§ Recognizing the varied information needs of different audiences and the importance of “marketing”
evidence to different audiences, not just disseminating it
§ Global-level web repositories or packaging of information to encourage access and collaboration
§ Having research “teams” comprising those working on both the research and the
use/communication of that research, and ensuring appropriate timing of engagement of all parties
§ Using various means of communicating evidence including briefs, video, e-mail digests, etc.
It was agreed that public health is the intersection of both politics and science, which reflects the idea that
decision-makers and researchers should be working as partners to ensure that needed questions are being
generated, that research asks these questions in the right way, and that the evidence generated will be used to
translate research into practice.

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/291982/HTN-strength-evidencemarch2014.pdf
3
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Recommendations
The recommendations that emerged from the Bellagio consultation fall into four major categories: Global
mechanisms, country mechanisms, implementation research and decision science (IRDS), and packaging and
communication of evidence.

I. GLOBAL MECHANISMS
Among sources of evidence, the discussion highlighted that WHO global guidance is one of the most trusted,
particularly when other sources of evidence are scarce. Country decision-makers recognize that national
health systems see the value of and benefit from global guidance, particularly guidance developed by the
WHO. However, it was also acknowledged that global guidance can’t answer every question, particularly
when it comes to local context.
a. The relevance and applicability of WHO guidance could be further strengthened by applying new methodologies for
synthesizing and appraising a broader range of evidence, such as evidence from qualitative studies and complex
interventions.

The meeting participants also underscored a conclusion from the Croydon meeting that “different decisions
require different types of evidence generated through different study designs; consequently the utility of
research-based evidence will depend on its capacity to inform a particular decision.” The flexibility of having
multiple study design options may better allow for non-traditional sources of evidence, such as grey literature,
expert opinion, and implementation experience to be taken into account. This broad range of sources allows
for a nuanced interpretation of evidence that can address a wider range of questions, such as: Who directly
benefits from program investments? In what context? This also allows for the incorporation of additional
dimensions such as scale and cost of intervention implementation. Taken together, WHO guidance and
complementary sources of evidence may provide a more comprehensive interpretation for policy makers.
b. We recognize that policy makers and program managers have a range of information needs that cannot be addressed
with WHO guidance alone. Therefore, we stress the need for continued investment in complementary processes,
resources, and capabilities at all levels for generating, synthesizing and communicating evidence.

Inconsistent knowledge about and messaging of new research findings at the global and country levels can
hamper evidence-based programming at the country level.
c. Development partners including UN organizations must ensure alignment and consistency of messaging for research
findings and results at the regional and country levels.

At the country level, decision-makers are often faced with immediate or urgent needs for evidence or
information. In these instances, there is no time for a study to generate evidence, and decision-makers are
often left rushing to find relevant evidence in which they feel confident.
d. Development partners should work with countries to explore the potential of response mechanisms designed to address
information needs in a timely manner.
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II. COUNTRY MECHANISMS
Though global guidelines, recommendations, and platforms are important for evidence generation and use,
action at the country level is critical. Numerous development partners invest in valuable research, however
these efforts are not well-coordinated and results are not consistently communicated or made available at the
country level. As a result, opportunities for utilization and scale up of research evidence are often missed.
a.

There is a need for coordination of research activities and organization of knowledge resources at the global and country
levels. As a first priority, countries and development partners are encouraged to create a publicly accessible, searchable
research repository at the national level. This repository would be managed and maintained by a relevant national
organization. These organizations may require technical and/or financial assistance to strengthen their capacity to
manage and maintain this repository.

b.

Governments and development partners are encouraged to support national and/or sub-national research symposiums,
coordinated through the Ministry of Health and/or other relevant government bodies, to foster knowledge management
and consensus building around research results and knowledge gaps.

International synthesis and guidance, following standardized and agreed upon principles and procedures,
provides a widely accepted consensus on research findings. However, to best serve the needs and address the
unique challenges of countries at the national and sub-national levels, international guidance must be
contextualized to the local situation, and countries need tools to help make policy and program decisions
appropriate for local contexts.
c.

To implement evidence-based change, countries require consultative processes, resources, and capabilities for generating,
synthesizing, and using locally appropriate evidence. Countries also need to be supported in adapting global guidelines
for local use.

d.

Policy makers and program managers are encouraged to build local capacity for and use underutilized decision-making
tools, such as Root Cause Analysis and Bottleneck Analysis, to better identify underlying causes of program constraints
and bottlenecks.

Leaders must then garner support for evidence-based policy and program change.
e.

Countries are encouraged to build capacity at the national and sub-national levels to use evidence-based
strategies/mechanisms to garner support for policy and program change. Such strategies could include, but are not
limited to, developing leadership within Ministries to advocate for change, identifying and supporting in-country
champions, broadening stakeholder engagement, capacity building of policy makers and other key stakeholders for
advocacy, and study tours.

III. IMPLEMENTATION RESEARCH AND DELIVERY SCIENCE (IRDS)
In order to meet national and international development goals, countries must move from pilot or
demonstration projects that generate evidence of improved health service delivery and system improvements
to nationwide implementation and institutionalization of high impact practices.
a.

To be most effective, scale-up of interventions with demonstrated effectiveness through pilot projects should include
processes for continual learning and adaptation as scale-up proceeds, sometimes referred to as Implementation Research
and Delivery Science (IRDS).
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We recognize and applaud IRDS as a platform that brings together key development partners in an effort to
introduce mechanisms to embed implementation research into policy making, program management, and
monitoring and evaluation processes.
b.

To operationalize this effort, governments should consider embedding IRDS in national plans and policies. Countries
are encouraged to start with a review of the Cape Town Statement on IRDS. 4
3F

IV. COMMUNICATING AND PACKAGING EVIDENCE
It is important that there is a plan to encourage the use of evidence that is generated. Packaging and
communication are key elements of evidence use, so that the intended audiences receive the evidence in a
clear and compelling way that will bring it into the multi-dimensional decision-making process and lead to
evidence-based change.
Access to evidence is a basic, yet not always simple, element of utilization. However there is a trend,
particularly among the donor community and multi-lateral organizations, to ensure open access to journal
articles – at a minimum for developing country audiences, who otherwise might not have the resources to
access these journals.
a.

Recognizing the trend towards more open access, we encourage more journals to provide open access mechanisms and
more researchers to publish in open access journals. To aid in operationalization of intervention research, we also
encourage researchers and journals to include supplemental materials on the description of the intervention, beyond
what space limitations make it possible to include in the article.

b.

WHO and development partners should raise awareness of the availability of free journal access through the
HINARI website (who.int/HINARI) to health institutions in developing countries.

Additionally, those using evidence to influence the decision-making process are not a homogenous group.
They have diverse opinions, preferences for receiving messages about new evidence, and formats in which
they prefer to have evidence delivered.
c.

To increase research utilization, researchers/research teams should segment audiences and settings by use of different
messaging, tools, platforms, and packaging (e.g. multimedia, Twitter, listserv emails, HIP map).

Finally, the responsibility for research utilization should not rest solely on the researcher. Research utilization
should begin at the stage of question identification, involving those with a variety of expertise, including those
who can help develop and plan for evidence use and those local stakeholders who can influence its use.

4

d.

Research proposals should include research utilization plans, and research teams should include members with a
variety of skills who will help to translate the findings into action throughout the research process and not only at the
end.

e.

Country programs will benefit from greater utilization of evidence and data for decision making. Therefore, policy
makers and other local stakeholders should seek ways to incorporate research utilization into decision-making
processes.

http://healthsystemsglobal.org/upload/hsg_media/statement_IRDS.pdf?view-version=1.0
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Appendix 1 | Meeting Agenda
TIME

SESSION/OBJECTIVES

DISCUSSION QUESTIONS/
KEY POINTS

SESSION MODERATORS/
DISCUSSANTS

TUESDAY FEBRUARY 9TH
8:00 am –
9:00 am

9:15 am –
9:30 am

BREAKFAST
MODERATORS
Karen Hardee, Evidence
Project/Population Council

Welcome, participant introductions,
overview of the meeting, logistics

Harriet Birungi, STEPUP/Population Council
Objective 1

9:30 am –
10:15 am

Rationale and objectives for this
consultation:
§ Overview of previous
consultations
§ Contribution of this meeting to
standards of evidence and
rationale and expectations for
this meeting
§ Expected product outcomes
Facilitated discussion among
country decision-makers using
questions from the pre-meeting
survey
Objective 2

10:15 am –
11:15 am

The world of policy and program
from the decision-maker
perspective: what is the role for
research-based evidence, among
other factors?
§ Group-wide understanding of
decision-making processes in
diverse situations
§ Examples of how and when
research-based evidence is and
is not used
§ Key constraints in using
evidence

§ Link this meeting to
previous meetings to clarify
rationale for this
consultation
§ Brief overview of
recommendations from
previous meetings
§ Define products of meeting
(audience, what will they
look like?)
Role of research-based
evidence in making decisions:
§ What decisions are
decision-makers faced with
for which evidence could be
helpful?
§ How often are you faced
with these decisions?
§ What time frame do you
have to make these
decisions? (a week, month,
etc.)
§ Are there other
constraints/parameters
that influence decisions?
§ How do decision-makers
use evidence? (inform
decisions, justify decisions,
inform implementation)

MODERATORS
Ian Askew, WHO
Shawn Malarcher, USAID

MODERATORS
Patrick Aboagye, Ghana
Health Service

THE EVIDENCE PROJECT | 9

TIME

SESSION/OBJECTIVES

DISCUSSION QUESTIONS/
KEY POINTS

SESSION MODERATORS/
DISCUSSANTS

§ Where do decision-makers
go for input/advice? Why
these sources?
§ What are the key
constraints to accessing
and using research-based
evidence? Which of these
can be addressed by
producers of evidence?

MODERATORS
Patrick Aboagye, Ghana
Health Service

§ What can producers of evidence
do to make research more
accessible/usable for decisionmakers?
11:15 am –
11:30 am

BREAK

Continuation of discussion
11:30 am12:45 pm

12:45 pm –
2:15 pm

The world of policy and program
decision-making; what is the role for
research-based evidence, among
other factors?

LUNCH
Key issues related to standards of
evidence. Short presentations and
facilitated discussions on four
issues.

2:15 pm –
3:45 pm

Issue 1: Standards and types of
evidence for demonstrating
effectiveness of ‘clinical,’ ‘public
health,’ and multisectoral
interventions
Issue 2: Using Implementation
Research to inform scale up and
improve program efficiency
Issue 3: Summarizing bodies of
evidence: what’s behind the existing
guideline acronyms?

3:45 pm –
4:00 pm

BREAK
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§ Articulate the differences
between standards and
types of evidence needed
for ‘clinical’ and ‘public
health’ RH/FP interventions
and quality of evidence
§ How is Implementation
Research different than
impact studies? What is the
value added?
§ Using different methods
can yield different answers
(impact assessments as
well as systematic reviews)

MODERATORS
Issue 1: Karen Hardee,
Evidence Project/
Population Council
Issue 2: Nhan Tran, AHSPR
Issue 3: Özge Tunçalp,
WHO

TIME

SESSION/OBJECTIVES

4:00 pm –
4:45 pm

Issue 4: What is the role of politics
and expert opinion in assessing
standards of evidence?

4:45 pm –
5:15 pm

Other issues in research evidence:
cost data, quality of evidence,
measuring sustainability

7:00 pm –
8:30 pm

DINNER

DISCUSSION QUESTIONS/
KEY POINTS

SESSION MODERATORS/
DISCUSSANTS
MODERATOR
Issue 4: Josephine KibaruMbae, NCPD, Kenya

Discussion of other issues that
arise related to evidence,
including questions about
evidence from participants

MODERATOR
Kazuyo Machiyama,
LSTHM

WEDNESDAY FEBRUARY 10TH

8:00 am –
9:00 am

9:15 am –
9:25 am

9:25 am –
9:45 am

BREAKFAST

MODERATOR
Tapash Das, DGFP,
Bangladesh

Recap of key points and highlights
from Day 1

Finalize draft recommendations
from Day 1

Review and reach agreement
on wording of the draft
recommendation statements
for objectives #1 and #2

MODERATOR
Ian Askew, WHO

What mechanisms does your
ministry currently have in place
to:

Objective 3
9:45 am –
10:45 am

Moderated discussion with decisionmakers

§ Set and manage a research
agenda
§ Commission or otherwise
fund research studies
§ Coordinate and receive
evidence from national
universities / research
organizations

MODERATOR
Susan Elden, DFID
DISCUSSANTS
Country decision-makers

To what extent do these
mechanisms include
opportunities for the different
types of research discussed on
day 1?
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TIME

SESSION/OBJECTIVES

DISCUSSION QUESTIONS/
KEY POINTS

SESSION MODERATORS/
DISCUSSANTS

How could these mechanisms
be improved to generate the
quality of evidence needed?

10:45 am –
11:00 am

BREAK
You’ve heard from the country
decision-makers.

11:00 am 12:00 pm

Moderated discussion with donors
and researchers

§ What have your
experiences been as
donors, including both
successes and challenges,
in supporting country-led
research?
§ From the discussion we’ve
had, can you think of ways
that donors and the
research programs they
fund could better support
countries to improve their
mechanisms for generating
and synthesizing research,
and for using evidence to
inform nationallyappropriate programming?

12:00 pm –
12:45 pm

12:45 pm –
1:00 pm

Look at examples of evidence
packaging and discuss how these
formats could be made more useful
for policy makers.

GROUP PHOTO
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Koku Awoonor-Williams,
Ghana Health Service
DISCUSSANTS
Representatives from
USAID, DfID, WHO, UNFPA,
the Evidence Project, StepUp Project

MODERATORS
Shawn Malarcher, USAID

Objective 4
Effective packaging and
communication of evidence (Group
discussion)

MODERATORS

§ What do you like about
each format? What would
you change and how?
§ Does it include the
information you need?
§ Is it written in a way that is
easy to understand and
use?
§ Where do you go to get
information?

DISCUSSANTS
MD Younus Mian, MOHFW,
Bangladesh
(journal article)
Placid Mihayo, MOH,
Uganda
(FP HIPs)
Chito Nelson, NPHCDA,
Nigeria (WHO Task Shifting
guidance)

TIME

SESSION/OBJECTIVES

1:00 pm –
2:15 pm

LUNCH

2:15 pm –
3:45 pm

Continue discussion on effective
packaging and communication of
evidence

3:45 pm –
4:00 pm

BREAK

4:00 pm –
5:00 pm

Address Parking Lot topics from
prior two days

7:00 pm –
8:30 pm

DINNER

DISCUSSION QUESTIONS/
KEY POINTS

SESSION MODERATORS/
DISCUSSANTS

MODERATOR
Shawn Malarcher, USAID

MODERATOR
Robin Keeley, Evidence
Project/PATH

THURSDAY FEBRUARY 12TH
8:00 am –
9:00 am

BREAKFAST

9:15 am –
9:25 am

Recap of key points and highlights
from Day 2

9:25 am –
9:45 am

Finalize draft recommendations
from Day 2

MODERATOR
Naeem Zafar, Ministry of
Planning, Development &
Reform, Pakistan
Draft the agreed-upon
recommendations as short,
action-oriented bullet points
that can be framed as a
consensus statement

MODERATOR
Harriet Birungi, STEPUP/Population Council

Objective 5
Preparing a consensus statement
9:45 am –
11:00 am

Group Discussion: Reflecting on the
recommendations from the Croyden
meeting, discuss key points of
agreement from the consultation on
standards of evidence from the
perspective of decision-makers,
including design and
implementation of research to help

Recommend processes to
better align research with
decision-makers’ needs

MODERATORS
Karen Hardee, Evidence
Project/Population Council
Shawn Malarcher, USAID
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TIME

SESSION/OBJECTIVES

DISCUSSION QUESTIONS/
KEY POINTS

SESSION MODERATORS/
DISCUSSANTS

decision-makers, and the synthesis,
packaging and communication of
research results to best reach
decision-makers
11:00 am –
11:15 am

11:15 am –
12:45 pm

BREAK
Final recommendations for the
consensus statement. Discussion on
plans for preparation of consensus
statement and meeting report,
including authorship and process for
finalizing the report, publication and
dissemination.
Evaluation
Wrap-up
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The purpose of the consensus
statement is to inform and
influence the funding, design,
implementation and
communication of research on
reproductive and maternal
health policies and programs in
developing countries.

MODERATORS
Karen Hardee, Evidence
Project/Population Council
Harriet Birungi, STEPUP/Population Council

Appendix 2 | List of Participants
NAME

COUNTRY

TITLE

ORGANIZATON

Mr. MD Younus Mian

Bangladesh

Deputy Chief (Planning
Wing)

Dr. Tapash Ranjan Das

Bangladesh

Deputy Director, MCH

Ministry of Health and
Family Welfare
Directorate General of
Family Planning

Dr. Patrick Aboagye

Ghana

Dr. Koku AwoonorWilliams

Ghana

Dr. Josephine KibaruMbae

Kenya

Director General

Mrs. Chito Nelson

Nigeria

Deputy Director (HSS)

Dr. Naeem-uz-Zafar

Pakistan

Member, Social Sectors &
Devolution

National Council for
Population and
Development
National Primary Health
Care Development
Agency
Ministry of Planning,
Development & Reform

Dr. Placid Mihayo

Uganda

Assistant Commissioner RH

Ministry of Health

Dr. Ian Askew

Switzerland

Dr. Özge Tuncalp

Switzerland

Dr. Nhan Tran

Switzerland

Ms. Shawn Malarcher

USA

Mr. Neal Brandes

USA

Mrs. Susan Elden

United
Kingdom

Dr. Karen Hardee

USA

Ms. Robin Keeley

USA

Dr. Harriet Birungi

Kenya

Dr. Kazuyo Machiyama

United
Kingdom

Faculty

London School of
Hygiene & Tropical
Medicine

Dr. Eugene Kongnyuy

DRC

H4+ Coordinator and Chief
Technical Advisor

UNFPA

Director of Family Health
Division
Director of Policy Planning
Monitoring & Evaluation

Ghana Health Service

Ghana Health Service

Director, Department of
Reproductive Health and
Research
Department of Reproductive
Health and Research
Alliance for Health Policy
and Systems Research
Senior Best Practices
Utilization Advisor
Research Advisor

WHO
WHO
WHO
USAID
USAID

Health Adviser, Human
Development Research
Team, Research and
Evidence Division
Senior Associate and Project
Director
Research Utilization
Specialist
Kenya Population Council
Country Director and Project
Director

DfID
The Evidence Project,
Population Council
The Evidence Project,
PATH
STEP UP Project,
Population Council
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The Evidence Project
Population Council
4301 Connecticut Avenue, NW, Suite 280
Washington, DC 20008 USA
tel +1 202 237 9400
evidenceproject.popcouncil.org
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